Peter Meyer Bio

Dr. Peter Meyer is a Managing Director at Outcome Capital with over 25 years of strategic investment and commercial execution experience in MedTech and the life sciences. With a professional focus on market entry and growth acceleration, he has represented buy-side and sell-side interests across a wide range of clinical segments and business models. Prior to joining Outcome Capital, Dr. Meyer was Vice President of Strategy and Corporate Development at Vicarious Surgical, an early-stage developer of soft-tissue surgical robotics. He previously served as Senior Director of Business Development for Insulet Corporation, orchestrating investments in margin and portfolio expansion for this leading manufacturer of diabetes technology. In a series of increasingly senior roles within MedTech giants Medtronic and Covidien, Dr. Meyer oversaw corporate transformational growth programs and implemented industry best-practices for strategic business optimization. Dr. Meyer earned a Ph.D. in Biomedical Engineering from Boston University, a B.S. in Mechanical Engineering from Columbia University, and a B.S. in Math, Physics, & Chemistry from Providence College. He is a certified Design for Six Sigma Black Belt and holds over 30 patents in medical technology. He is a FINRA Registered Securities Representative holding Series 79 and 63 registrations.